But when the Recovery trial came out with a rigorous, definitive answer of ‘No, it doesn’t work,’ everything quieted down,” says Hernandez.
Health care workers gave hospitalized people the drug in the early days of the pandemic (because they didn’t have much else to give), and influential voices like carmaker Elon Musk and President Donald Trump advocated for it as a possible cure.
As a manufacturer of hydroxychloroquine, the company was in the uncomfortable position of distributing a product that was overhyped for an unintended—and, as the FDA concluded, not likely to be effective —use as a Covid-19 treatment or preventative drug.
When The Lancet and The New England Journal of Medicine pulled an influential pair of Covid-19 papers last Thursday, it was a rare event in scientific publishing.Could these be among “the biggest retractions in modern history,” as one observer described the news about the paper in The Lancet?